ISSN: 1838-7640Theranostics
Global reach, higher impact
Theranostics 2023; 13(12):3964-3965. doi:10.7150/thno.85930 This issue Cite
Erratum
N6-methyladenosine-induced ERRγ triggers chemoresistance of cancer cells through upregulation of ABCB1 and metabolic reprogramming: Erratum
Zhuojia Chen2#, Long Wu1,3#, Jiawang Zhou1#, Xinyao Lin1#, Yanxi Peng1, Lichen Ge1,4, Cheng-Ming Chiang5, Hui Huang6, Hongsheng Wang1 
, Weiling He7
1. Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, Guangdong 510006, China
2. Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
3. Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
4. Department of Clinical Laboratory, Jinling Hospital, Nanjing University School of Medicine, 305 East Zhongshan Road, Nanjing 210002, China
5. Simmons Comprehensive Cancer Center, Department of Pharmacology, and Department of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390, USA
6. Cardiovascular Department, The Eighth Affiliated Hospital, Sun Yat-sen University, Shennan Middle Road 3025#, Shenzhen, 518033, China
7. Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China
# These authors contributed equally to this work.
Citation:
Chen Z, Wu L, Zhou J, Lin X, Peng Y, Ge L, Chiang CM, Huang H, Wang H, He W. N6-methyladenosine-induced ERRγ triggers chemoresistance of cancer cells through upregulation of ABCB1 and metabolic reprogramming: Erratum. Theranostics 2023; 13(12):3964-3965. doi:10.7150/thno.85930. https://www.thno.org/v13p3964.htm
Other stylesCorrected-article in Theranostics, Volume 10, 3382
The authors regret to inform the readers that wrong selections of the relative insets may have occurred for Figure 1 D and Figure 7 D. The analyses have been performed on n=3 samples for each concentration and are not questionable. In order to reduce the misunderstanding that may be caused in the future, we replaced the images and bands with the alternative ones. It is now correct in the below pictures.
The authors would like to apologise for any inconvenience caused.
Figure 1
Corrected figure for the original Figure 1 D.
Figure 7
Corrected figure for the original Figure 7 D.
Author contact
Corresponding authors: Dr. HS Wang, Email: whongshsysu.edu.cn, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China; Dr. Weiling He, Email: hewlingsysu.edu.cn, Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China
Published 2023-7-6
Citation styles
APA
Chen, Z., Wu, L., Zhou, J., Lin, X., Peng, Y., Ge, L., Chiang, C.M., Huang, H., Wang, H., He, W. (2023). N6-methyladenosine-induced ERRγ triggers chemoresistance of cancer cells through upregulation of ABCB1 and metabolic reprogramming: Erratum. Theranostics, 13(12), 3964-3965. https://doi.org/10.7150/thno.85930.
ACS
Chen, Z.; Wu, L.; Zhou, J.; Lin, X.; Peng, Y.; Ge, L.; Chiang, C.M.; Huang, H.; Wang, H.; He, W. N6-methyladenosine-induced ERRγ triggers chemoresistance of cancer cells through upregulation of ABCB1 and metabolic reprogramming: Erratum. Theranostics 2023, 13 (12), 3964-3965. DOI: 10.7150/thno.85930.
NLM
Chen Z, Wu L, Zhou J, Lin X, Peng Y, Ge L, Chiang CM, Huang H, Wang H, He W. N6-methyladenosine-induced ERRγ triggers chemoresistance of cancer cells through upregulation of ABCB1 and metabolic reprogramming: Erratum. Theranostics 2023; 13(12):3964-3965. doi:10.7150/thno.85930. https://www.thno.org/v13p3964.htm
CSE
Chen Z, Wu L, Zhou J, Lin X, Peng Y, Ge L, Chiang CM, Huang H, Wang H, He W. 2023. N6-methyladenosine-induced ERRγ triggers chemoresistance of cancer cells through upregulation of ABCB1 and metabolic reprogramming: Erratum. Theranostics. 13(12):3964-3965.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.